ARMATA PHARMACEUTICALS, INC. Intangible Assets, Net (Including Goodwill)
ARMATA PHARMACEUTICALS, INC. (ARMP) had Intangible Assets, Net (Including Goodwill) of $20.39 million as of 2014-09-30, per its 10-Q/A filed 2015-04-15.
Discontinued › Notes › Goodwill and Other
us-gaap:IntangibleAssetsNetIncludingGoodwill · last filed 2015-04-15
- 2014-09-30: Intangible Assets, Net (Including Goodwill) $20.39M; Intangible Assets, Net (Including Goodwill) as first filed $17.15M.
- 2014-06-30: Intangible Assets, Net (Including Goodwill) $20.39M; Intangible Assets, Net (Including Goodwill) as first filed $17.16M.
- 2014-03-31: Intangible Assets, Net (Including Goodwill) $20.40M; Intangible Assets, Net (Including Goodwill) as first filed $17.17M.
- 2013-12-31: Intangible Assets, Net (Including Goodwill) $20.41M; Intangible Assets, Net (Including Goodwill) as first filed $17.18M.
| Period end | Intangible Assets, Net (Including Goodwill) | Intangible Assets, Net (Including Goodwill) as first filed |
|---|---|---|
| 2014-09-30 | $20.39M 10-Q/A · filed 2015-04-15 | $17.15M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $20.39M 10-Q/A · filed 2015-04-15 | $17.16M 10-Q · filed 2014-09-12 |
| 2014-03-31 | $20.40M 10-Q/A · filed 2015-04-15 | $17.17M 10-Q · filed 2014-09-12 |
| 2013-12-31 | $20.41M 10-Q/A · filed 2015-04-15 | $17.18M 10-Q · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |